A0001 - RFQ: Physician Authorized Genetics Testing for MEDVAMC

The Department of Veterans Affairs (VA), specifically the Michael E. DeBakey VA Medical Center (MEDVAMC) Pathology & Laboratory Medicine Service, is seeking a contractor to provide comprehensive physician-authorized genetic testing services through a Single Awarded Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The solicitation covers over 200 specific genetic tests across multiple categories including cancer, cardiovascular, neurological, metabolic, immunological, and rare genetic disorders. Contractors must be actively registered in the System for Award Management (SAM) and will be evaluated based on their ability to provide high-quality, precise genetic screening and analysis. The key response dates include a questions deadline of March 20, 2025, and a quote submission deadline of April 3, 2025. Quotes will be evaluated under the commercial items procedures outlined in Federal Acquisition Regulation (FAR) subpart 12.6 and Part 13.5.

This procurement is designated as a Total Small Business Set-Aside under the North American Industrial Classification System (NAICS) code 621511, with a size standard of $41.5 Million. The contract will have a base year from award to September 30, 2025, with four additional 12-month option years potentially extending through September 30, 2029. The place of performance is Houston, TX 77030, and the estimated volume is approximately 700 total tests, including 625 Hereditary Cancer Diagnostic Panels or Single Genes and 75 Other Diagnostic Panels or Single Genes. There is no incumbent contractor, as this is a new contract, and it is confirmed to be funded. The solicitation emphasizes the critical nature of these genetic tests for diagnosing veteran patients, determining medical management, and supporting reproductive planning through carrier screening aligned with national guidelines.